{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "70748-236",
      "generic_name": "Azilsartan medoxomil",
      "labeler_name": "Lupin Pharmaceuticals, Inc.",
      "brand_name": "Azilsartan medoxomil",
      "active_ingredients": [
        {
          "name": "AZILSARTAN KAMEDOXOMIL",
          "strength": "40 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "70748-236-06",
          "description": "30 TABLET in 1 BOTTLE (70748-236-06)",
          "marketing_start_date": "20260514",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Lupin Pharmaceuticals, Inc."
        ],
        "rxcui": [
          "1091646",
          "1091652"
        ],
        "spl_set_id": [
          "b1c8de43-3b26-408f-8c7e-6c7d76348199"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0370748237069",
          "0370748236062"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET",
      "spl_id": "f05aba4d-376f-460f-9264-ecf267e04dcd",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20260514",
      "product_id": "70748-236_f05aba4d-376f-460f-9264-ecf267e04dcd",
      "application_number": "ANDA214489",
      "brand_name_base": "Azilsartan medoxomil",
      "pharm_class": [
        "Angiotensin 2 Receptor Blocker [EPC]",
        "Angiotensin 2 Type 1 Receptor Antagonists [MoA]",
        "Decreased Blood Pressure [PE]"
      ]
    }
  ]
}